Lin, Yong

MONARCH 2: abemaciclib in combination with fulvestrant in women with HR+/HER2- advanced breast cancer who had progressed while receiving endocrine therapy

Sledge, G. W., Toi, M., Neven, P., Sohn, J., Inoue, K., Pivot, X., Burdaeva, O., Okera, M., Masuda, N., Kaufman, P. A., et al. (2017) · Journal of Clinical Oncology

Advanced Breast Cancer TherapiesBreast Cancer Treatment Studies

Cited by 1,680

Adverse Experiences in Early Childhood and Kindergarten Outcomes

Jimenez, M. E., Wade, R., Lin, Y., Morrow, L. M., & Reichman, N. E. (2016) · Pediatrics

Child Abuse and TraumaEarly Childhood Education and Development

Cited by 365

Ultra-Processed Foods and Incident Cardiovascular Disease in the Framingham Offspring Study

Juul, F., Vaidean, G., Lin, Y., Deierlein, A. L., & Parekh, N. (2021) · Journal of the American College of Cardiology

Consumer Attitudes and Food LabelingNutritional Studies and Diet

Cited by 227

Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non–Small Cell Lung Cancer: A Nonrandomized Controlled Trial

Jabbour, S. K., Berman, A. T., Decker, R. H., Lin, Y., Feigenberg, S. J., Gettinger, S. N., Aggarwal, C., Langer, C. J., Simone, C. B., Bradley, J. D., et al. (2020) · JAMA Oncology

Lung Cancer Diagnosis and TreatmentCancer Immunotherapy and Biomarkers

Cited by 125

Adverse Childhood Experiences and ADHD Diagnosis at Age 9 Years in a National Urban Sample

Jimenez, M. E., Wade, R., Schwartz-Soicher, O., Lin, Y., & Reichman, N. E. (2017) · Academic Pediatrics

Child Abuse and TraumaAttention Deficit Hyperactivity Disorder

Cited by 104

Prognostic characteristics in hormone receptor-positive advanced breast cancer and characterization of abemaciclib efficacy

Di Leo, A., O’Shaughnessy, J., Sledge, G. W., Martin, M., Lin, Y., Frenzel, M., Hardebeck, M. C., Smith, I. C., Llombart-Cussac, A., Goetz, M. P., et al. (2018) · npj Breast Cancer

Advanced Breast Cancer TherapiesBreast Cancer Treatment Studies

Cited by 66